Literature DB >> 21316557

[Comorbidities in COPD].

Javier de Miguel Díez1, Teresa Gómez García, Luis Puente Maestu.   

Abstract

The comorbidities of chronic obstructive pulmonary disease (COPD) consist of all the alterations and disorders associated, for one reason or another, with this disease. These comorbidities may be causal (other diseases also caused by smoking, such as ischemic heart disease or lung cancer), a complication (pulmonary hypertension or heart failure), a concurrence (disorders related to advanced age such as hypertension, diabetes mellitus, depression or osteoarthritis) or an intercurrent process (an acute process, generally time-limited, such as a respiratory infection). Of all these comorbidities, those most frequently associated with COPD are hypertension, diabetes mellitus, infections, cancer and cardiovascular diseases. Comorbidities in COPD not only increase the social repercussions and annual cost of the disease but are also a prognostic factor for mortality in affected individuals. Indeed, in addition to respiratory failure, frequent causes of death in patients with COPD are ischemic heart disease and malignancies. The present article discusses the comorbidities of COPD with the greatest impact due to their frequency or influence on mortality. Although not precisely known, the common mechanism of all these comorbidities could be systemic inflammation and its mediators, which play an important role in the pathogenesis of COPD.
Copyright © 2010 Sociedad Española de Neumología y Cirugía Torácica. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21316557     DOI: 10.1016/S0300-2896(10)70058-2

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  9 in total

Review 1.  Physical activity in chronic respiratory conditions: assessing risks for physical activity clearance and prescription.

Authors:  Jamie F Burr; Warren Davidson; Roy J Shephard; Neil Eves
Journal:  Can Fam Physician       Date:  2012-07       Impact factor: 3.275

2.  Prevalence and Comorbidities of Chronic Obstructive Pulmonary Disease Among Adults in Kentucky Across Gender and Area Development Districts, 2011.

Authors:  Abdulbaset Kamour; Mannino David; Sarojini Kanotra
Journal:  Chronic Obstr Pulm Dis       Date:  2015-10-15

3.  Readmission Due to Exacerbation of COPD: Associated Factors.

Authors:  Alicia Cerezo Lajas; Enrique Gutiérrez González; César Llorente Parrado; Luis Puente Maestu; Javier de Miguel-Díez
Journal:  Lung       Date:  2018-02-14       Impact factor: 2.584

4.  The effect of quitting smoking on costs and healthcare utilization in patients with chronic obstructive pulmonary disease: a comparison of current smokers versus ex-smokers in routine clinical practice.

Authors:  Antoni Sicras-Mainar; Javier Rejas-Gutiérrez; Ruth Navarro-Artieda; Jordi Ibáñez-Nolla
Journal:  Lung       Date:  2014-05-10       Impact factor: 2.584

5.  Independent effect of prior exacerbation frequency and disease severity on the risk of future exacerbations of COPD: a retrospective cohort study.

Authors:  Miguel Santibañez Margüello; Roberto Garrastazu; Mario Ruiz-Nuñez; Jose Manuel Helguera; Sandra Arenal; Cristina Bonnardeux; Carlos León; Marc Miravitlles; Juan Luis García-Rivero
Journal:  NPJ Prim Care Respir Med       Date:  2016-09-08       Impact factor: 2.871

6.  Prevalence of obstructive airway disease by spirometric indices in non-smoker subjects with IHD and HTN.

Authors:  Virendra C Patil; Bhupal N Pujari; Harsha V Patil; Amit Munjal; Vaibhav Agrawal
Journal:  Lung India       Date:  2012-07

7.  Differences in the Outcome of Patients with COPD according to Body Mass Index.

Authors:  Zichen Ji; Javier de Miguel-Díez; Christian Reynaldo Castro-Riera; José María Bellón-Cano; Virginia Gallo-González; Walther Iván Girón-Matute; Rodrigo Jiménez-García; Ana López-de Andrés; Virginia Moya-Álvarez; Luis Puente-Maestu; Julio Hernández-Vázquez
Journal:  J Clin Med       Date:  2020-03-05       Impact factor: 4.241

8.  Influence of Pneumonia on the Survival of Patients with COPD.

Authors:  Zichen Ji; Julio Hernández Vázquez; José María Bellón Cano; Virginia Gallo González; Beatriz Recio Moreno; Alicia Cerezo Lajas; Luis Puente Maestu; Javier de Miguel Díez
Journal:  J Clin Med       Date:  2020-01-15       Impact factor: 4.241

9.  Influence of Comorbidities on the Survival of COPD Patients According to Phenotypes.

Authors:  Zichen Ji; Julio Hernández-Vázquez; Irene Milagros Domínguez-Zabaleta; Ziyi Xia; José María Bellón-Cano; Virginia Gallo-González; Ismael Ali-García; Carmen Matesanz-Ruiz; Ana López-de-Andrés; Rodrigo Jiménez-García; María Jesús Buendía-García; Ángela Gómez-Sacristán; Walther Iván Girón-Matute; Luis Puente-Maestu; Javier de Miguel-Díez
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-10-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.